Furthermore, β.anti-NKG2A.IL-15 stimulated PBMCs killed 92% (± 3.62%) of Raji cells as compared to 28% (± 6.91%) for β.anti-NKG2A, emphasizing the requirement of IL-15 for an optimal cytotoxicity against resistant cancer cells. The gene discussed is KLRC1; the disease is cancer.